Sysmex needed find a way to introduce a new, smaller blood analysis machine to doctor's offices and other clinical settings, however FDA CLIA regulations seemingly required highly-skilled lab technicians, which would make operating costs prohibitively costly.
Sysmex, a leading manufacturer of best-in-class, in vitro diagnostic hematology and clinical laboratory products, is expanding care to millions of patients with the Sysmex XW-100, a smart, connected blood analyzer that can be easily deployed in doctor’s offices. The new analyzer enables blood test results to be delivered the same day, enabling same day diagnosis and rapid response.
The new Sysmex product contributes to the transformation of a healthcare ecosystem that is rapidly moving from “sick care” to “well care” through connected technologies.
It is no longer going to be sufficient to sell instruments. You’ve got to put a wrapper around them that demonstrates their value to the patient experience. Andy Hay, Chief Operating Officer, Sysmex America
Related Products and Solutions
- Expanded addressable market by 50-foldfrom 2,000 hospitals to over 100,000 doctor’s offices, by creating an IoT-based digital safety net
- Proved to the FDA that less skilled operators could achieve quality on a par with skilled technicians
- Reduced health care costs via smaller machines and less skilled operators
- Improved healthcare outcomes by enabling same-day results in clinical settings